FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| Edwards Lifesciences (NYSE: EW) | Delayed: 88.40 +0.11 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.29 | 52 Week High | $166.87 | |||
| Open | $87.52 | 52 Week Low | $72.20 | |||
| Day High | $89.32 | P/E | 25.70 | |||
| Day Low | $87.06 | EPS | $3.44 | |||
| Volume | 2,717,082 | |||||
